A new letter signed by more than 230 members of the House urges Congress to not only block the scheduled 2.8% reimbursement ...

Research further shows a significant association between patients with psoriasis and an increased incidence of obstructive ...

Seth Southwick, MHA, Intermountain Health, discusses in detail the power of leveraging community partnerships and advanced ...

A lot of attention has been on the drug price negotiation aspects of the Inflation Reduction Act (IRA), but the ...

The prevalence rates of metabolic dysfunction–associated steatohepatitis (MASH) and metabolic dysfunction–associated ...

The presenters outlined several key strategies to drive increased biosimilar adoption and utilization. One critical element ...

Toby Maher, MD, PhD, discusses how idiopathic pulmonary fibrosis (IPF) severely affects patients’ quality of life and daily ...

Bipolar disorder is commonly misdiagnosed depending on the features that present, explained Stephanie Hsia, PharmD, MAEd, ...

At our recent Institute for Value-Based Medicine® event in Boston, Hari Deshpande, MD, Yale Cancer Center, presented on ...

Experts explored the latest trends, approvals, and pipeline developments in cell and gene therapies, rare disease, immunology ...

As a result of vertical integration, health plans may have 2 different coverage policies on the medical benefit side and the ...

Artificial intelligence can revolutionize drug discovery by expediting development, reducing costs, and improving treatment ...